drugs

AstraZeneca, Bristol-Myers diabetes drug wins US OK - Reuters
Business Wire (press release)AstraZeneca, Bristol-Myers diabetes drug wins US OKReutersThe Food and Drug Administration said Onglyza was not linked to increased heart problems in low-risk patients but the agency was requiring future study ...FDA approves new drug treatment for type 2 diabetesXinhuaOnglyza Sanctioned for Type 2 DiabetesU.S. News %26 World ReportAstraZeneca still awaiting FDA news on OnglyzaReutersall 162 news articles��